Hands-on Laboratory Bootcamp for Cell Therapy Biomanufacturing

ABOUT THE COURSE

In this course, you will get to learn from experts about critical laboratory safety and gain the practical skills necessary to work competently in GLP and GMP-like laboratories.

This five-day, hands-on training teaches you the techniques central to cell and gene therapy manufacturing, including aseptic cell culture techniques, large-scale cell manufacturing, analytical techniques and product characterization, cell banking and documentation using GLP/GMP-like best practices.

COURSE CONTENT
  • Best practices for small- and large-scale cell manufacturing.
  • Fundamentals of working in GLP/GMP-like labs.
  • Setting up cell manufacturing bioreactors.
  • Analytical techniques, product evaluation and characterization.
  • GLP/GMP documentations. 
  • Recognize key components of the updated Hazard Communication Standard (HCS) under the Globally Harmonized System (GHS).

LEARNING OUTCOMES

  • Apply aseptic techniques and good laboratory practices to work in cell culture and GLP/GMP-like labs. 

  • Develop an understanding of the conditions to culture and maintain high-quality therapeutic cells. 

  • Perform key steps to initiate, maintain, and expand cells in culture. 

  • Understand key steps in the downstream processing of human cells, including harvesting and cryopreservation. 

  • Evaluate the quality and sterility of cell products. 

  • Apply GLP/GMP-like guidelines to document cell products. 

  • Distinguish hazards among the new standardized pictograms and gain knowledge on hazardous chemicals on the Safety Data Sheet (SDS). 

PRICE (USD)

Category IISCT or CMaT Member 
Academia $5,500
Industry $6,500
Students* $3,500


Limited time: Until June 2024, Academic and Industry registrants can receive  10% off the course price

*Student rate: Limited to two seats/course. Registrants must be enrolled in a post-secondary academic program.

Cancellation Policy: Registration cancellation must be made by email to isct@isctglobal.org at least twenty (20) business days before the course start date. A 10% administrative fee is applied to all cancellations.  Registration fee is non-refundable if it is cancelled within twenty (20) business days of the course start date.

ISCT reserves the right to cancel the course if we do not receive a minimum number of registrations twenty (20) business days in advance of the start date. Should the course be cancelled, your payment will be refunded in full. We recommend that you purchase travel insurance with your flights to cover the possibility of the course being cancelled.

UPCOMING COURSE DATES
  • April 29–May 3, 2024
    Deadline to register: March 29, 2024
    (registration open)

  • August 5–9, 2024
    Deadline to register: July 5, 2024
DESIGNED FOR:
  • Those seeking hands-on training experience working in GLP/GMP-like laboratory

STRUCTURE:
  • Small class size (10 people)
  • Five-day intensive course
  • Conducted in-person at Georgia Institute of Technology, Atlanta, Georgia, USA

ELIGIBILITY REQUIREMENTS:

UPON COMPLETION, YOU WILL RECEIVE:

  • A copy of the course materials
  • Certificates of course completion from ISCT-CMaT and CMLE

**ISCT is an ASCP Continuing Medical Laboratory Education (CMLE)-approved provider. This course consists of 30 CMLE credits.

CONTACT US

If you need help with registration or have questions, please contact us

“A well-trained, readily available, diverse workforce is crucial to the success of the emerging cell and gene therapy industry, especially given its highly specialized skill sets, GMP and regulatory requirements, and complex manufacturing and supply chain infrastructure.

Our partnership with ISCT brings the largest cell manufacturing research and education consortium together with the largest global cell & gene therapy society to deliver critically needed workforce training for CGT. Together, we hope to develop a robust, on-demand, client-centric training platform for industry and clinical manufacturers.”
-Krishnendu Roy, Robert A. Milton Chair, CMaT

“ISCT has long identified and taken measures to alleviate the skills shortages across the cell and gene therapy sector. ISCT has run a range of courses across the CGT sector, including forming our ISCT Early-Stage Professionals (ESP) Committee, responsible for our extensive Mentoring Program. Despite these efforts, growth in the CGT sector continues to outpace the professionals entering. This is a major issue for the sector that could become critical in the near future."
-Bruce Levine, Immediate-Past President, ISCT